This week, the WHO recommended four new treatments for patients with MDR-TB.
Three of the regimens were from the End TB trial, and one was from the BEAT-
Tuberculosis trial. All four new recommendations include shorter-course treatments, and
the End TB regimens include some of the first endorsements of short-course treatments
for children, adolescents, and pregnant women. Learn more here.
Comments